Patient Centricity & Pharma’s Reputation

Patient Centricity used to be a buzzword in that it was often mentioned but seldom practiced by pharma companies. A lot of progress has been made in the past years to achieve patient centricity, but not all drug companies have had much success. Unfortunately, that has had a negative impact on the industry's reputation.

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

Using Social Media as an Early Predictor of a New Drug’s Market Share

In this 5-minute interview, recorded 22 May 2013, Gideon Mantel of Treato discusses how social media can predict the success of a new drug launch much faster than traditional methods.

Shona Davies and Sean Nicholson: How Do You Define “Engagement?”

In this 3-minute audio snippet, Shona L. Davies, Communications & Programme Leader, Univadis, and Sean Nicholson, Senoir Director, Social Media, Intouch Solutions, define what they mean by social media

Jessica Federer: Empower Pharma Employees to Advance Digitalization in Your Organization

In this 1-minute audio snippet, Jessica Federer, Head of Digital Development at Bayer, talks about how Bayer employees its employees to advance the digitalization of the organization.

Pharmaguy™’s Twitter Stream – Q2 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Pharmaguy™’s Twitter Stream – Q3 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Tom Stossel: Debunking the “Conflict-of-Interest Narrative”

In this 5-minute audio snippet, Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, talks about what he calls the 'Conflict-of-Interest Narrative' or Myth, which is the subject of his new book, PharmaPhobia.

Jeff Tangney: How Doximity Creates Online Physician “Niche” Communities & Discussions

In this 2-minute audio snippet, Jeff Tangney, CEO & Founder, Doximity, talks about online physician chat rooms and how 'niche' communities are created around specific content posted to the site.

Arsalan Arif: Content Curation vs. Content Marketing. Is It All Crap?

In this 3-minute audio snippet, Arsalan Arif, Publisher of ENDPOINTS, talks about the benefits versus the drawbacks of content curation versus content marketing for pharmaceutical marketers.
- Advertisement -